Pradaxa Injury - Boehringer Ingelheim plays dumb

     This month it seems I've written a lot about medical problems and medical lawsuits. And now I find myself writing about another miracle drug that has been proved to do more harm than good in a lot of cases. Before that though , I must clarify that I am not under no circumstance advertising these pharmaceutical products ,nor am I trying to give them a bad name. A lot of people have been taking them and it improved their condition, but however there is still a great number of patients who have been complaining of some serious side-effects. Side-effects that in some cases put their life in danger.

     Pradaxa is an anticoagulant mainly used for treating pacients with  atrial fibrillation, a heart condition that leads to abnormal heart beats. Without treating, atrial fibrillation could lead to blood clots and strokes so an anticoagulant drug could mean the difference between life and death for those unfortunate to have this condition. 



     Pradaxa was released in 2010 , brought on the market by   Boehringer Ingelheim Pharmaceuticals and it quickly gain popularity over its predecesor and competitior, Warfarin, mainly for being more user-friendly as the patient does not need to do regular blood test or have any food restrictions. 
     
     However, the magic did not last long after it have been reported that Pradaxa may have some fatal side-effects as severe bleeding injuries were in patients who were taking Pradaxa, injuries that sometime lead to death. FDA was flooded with reports of victims suffering from internal bleedings after using the anticoagulant drug and by the second  quarter of 2011, the number of deaths sky-rocketed to 117.
     Symptomes included: 

            • Severe headaches
            • Repeated nosebleeds
            • Constant fatigue
            • Weakening or swelling in the body’s joints, arms, hands, legs, ankles or feet
            • Feeling dizzy
            • Unusual bruises or bleeding, particularly in the gums
            • Vomiting blood
            • Coughing up blood
            • Menstrual or vaginal bleeding that is heavier than normal

      Keep in mind that the FDA approved Pradaxa in October 2010 and here we are, less than a year later , 117 people died.  
     Despite this,  Boehringer Ingelheim, the pharmaceutical company responsible for Pradaxa ,  dabigatran by its chemical name, indirectly dismissed any accusation, by saying that Pradaxa is as safe as any anticoagulant drug on the market and the risk it's similar for any other blood thinner. I must admit, I'm not a doctor,or a pharmacist, but seeing as Pradaxa's popularity was mainly based on the "user-friendly" part I'm a little confused of how this drug has the same potential risk of its competitors that require some serious medical tests before administering. But like I said, I'm not an expert.

      To make things worse, while other blood thinners drugs had an antidote, Pradaxa had no such thing even though this thing was actually marketed as a good thing. The logic? Pradaxa is better , more efficient and also easier to use. 

       And things go further . This year, in January, a study conducted by researchers at the Cleveland Clinic and involving 30514 patients proved that the use of Pradaxa lead to a 33 percent higher risk of heart attack. 

       Wasn't Pradaxa supposed to do just the opposite? 
        So, where's   Boehringer Ingelheim Pharmaceuticals reaction? I guess as a cynical guy that I am the only thing I could do is point out the fact that maybe, striking deals with the victims cost a lot less than retreating the product of the market. 

         If what lead you to this article was the fact that you  or someone you know dealt with some serious problem because of Pradaxa the only thing I could recommend you is to seek the advice of a Pradaxa injury lawyer